| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA626: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure |
|
Medicine details |
|
| Medicine name | avatrombopag (Doptelet) |
| Formulation | 20 mg film-coated tablet |
| Reference number | 2425 |
| Indication | Treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure |
| Company | Swedish Orphan Biovitrum Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 20/03/2020 |
| NICE guidance | |
| Commercial arrangement | None |